NewslettersCell Therapy NewsUncategorizedChimeric Antigen Receptor (CAR) T-cell Treatment for Mantle Cell Lymphoma (MCL)By Justin.choi - March 3, 2022041Investigators provided an overview for the available management strategies for relapsed mantle cell lymphoma (MCL) and examines the role of CAR T cell in the current and future treatment of MCL.[Therapeutic Advances in Hematology] 6445212 BBBBBBBB items 1 apa 0 default asc 1 172479 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/Full Article